Technical Analysis for FSTX - F-star Therapeutics, Inc.

Grade Last Price % Change Price Change
C 10.14 9.03% 0.84
FSTX closed up 9.03 percent on Friday, April 16, 2021, on 3.56 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical FSTX trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish 9.03%
Multiple of Ten Bearish Other 9.03%
Older End-of-Day Signals for FSTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR 2 days ago
3x Volume Pace 2 days ago
2x Volume Pace 2 days ago
Possible Pocket Pivot 2 days ago
50 DMA Support 2 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the Company’s goal is to offer patients greater and more durable benefits than current immuno-oncology treatments. Through its proprietary tetravalent, bispecific antibody (mAb²™) format, F-star’s mission is to generate highly differentiated best-in-class drug candidates with monoclonal antibody-like manufacturability.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Clinical Medicine Immunology Immune System Antibodies Monoclonal Antibody Cancer Immunotherapy Antibody Tumor Treating Cancer Cancer Therapy Bispecific Monoclonal Antibody

Is FSTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.5
52 Week Low 3.884
Average Volume 109,777
200-Day Moving Average 7.54
50-Day Moving Average 10.02
20-Day Moving Average 10.69
10-Day Moving Average 10.08
Average True Range 1.10
ADX 13.11
+DI 23.46
-DI 21.44
Chandelier Exit (Long, 3 ATRs ) 12.19
Chandelier Exit (Short, 3 ATRs ) 12.53
Upper Bollinger Band 12.93
Lower Bollinger Band 8.46
Percent B (%b) 0.38
BandWidth 41.84
MACD Line -0.07
MACD Signal Line 0.10
MACD Histogram -0.1699
Fundamentals Value
Market Cap 91.97 Million
Num Shares 9.07 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.95
Resistance 3 (R3) 10.95 10.69 10.82
Resistance 2 (R2) 10.69 10.48 10.69 10.77
Resistance 1 (R1) 10.41 10.35 10.28 10.41 10.72
Pivot Point 10.15 10.15 10.08 10.15 10.15
Support 1 (S1) 9.87 9.94 9.74 9.87 9.56
Support 2 (S2) 9.61 9.81 9.61 9.51
Support 3 (S3) 9.33 9.61 9.47
Support 4 (S4) 9.33